Erik P Sulman

Erik P Sulman

UNVERIFIED PROFILE

Are you Erik P Sulman?   Register this Author

Register author
Erik P Sulman

Erik P Sulman

Publications by authors named "Erik P Sulman"

Are you Erik P Sulman?   Register this Author

90Publications

-Reads

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.

J Clin Oncol 2018 Aug 15;36(23):2386-2394. Epub 2018 Jun 15.

M. Catherine Pietanza, Lee M. Krug, Mark G. Kris, and Charles M. Rudin, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College; Kaitlin M. Woo, Yevgeniva Bensman, Brenda Hurtado, and Martin Fleisher, Memorial Sloan Kettering Cancer Center, New York, NY; Saiama N. Waqar, Washington University School of Medicine in St. Louis, St Louis, MO; Afshin Dowlati, Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, OH; Christine L. Hann, Johns Hopkins University, Baltimore; Alice Chen, National Institutes of Health, Bethesda, MD; Alberto Chiappori, H. Lee Moffitt Cancer Center, Tampa, FL; Taofeek K. Owonikoko, Emory University, Atlanta, GA; and Robert J. Cardnell, Junya Fujimoto, Lihong Long, Lixia Diao, Jing Wang, Patricia de Groot, Erik P. Sulman, Ignacio I. Wistuba, John V. Heymach, and Lauren Averett Byers, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article
August 2018

Melanoma brain metastases harboring BRAF or NRAS mutations are associated with an increased local failure rate following conventional therapy.

J Neurooncol 2018 Mar 2;137(1):67-75. Epub 2017 Dec 2.

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 97, Houston, TX, 77030, USA.

View Article
March 2018

A gene expression signature predicts recurrence-free survival in meningioma.

Oncotarget 2018 Mar 15;9(22):16087-16098. Epub 2018 Feb 15.

The University of Texas MD Anderson Cancer Center, Department of Translational Molecular Pathology, Houston, TX, USA.

View Article
March 2018

Large Scale Identification of Variant Proteins in Glioma Stem Cells.

ACS Chem Neurosci 2018 01 21;9(1):73-79. Epub 2017 Dec 21.

Center of Excellence in Biological and Medical Mass Spectrometry, Lund University , Klinikgatan 32, SE-221 84 Lund, Sweden.

View Article
January 2018

MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma.

Cancer Cell 2017 Dec;32(6):840-855.e8

Ken & Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; The Lou and Jean Malnati Brain Tumor Institute, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address:

View Article
December 2017

GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma.

Cell Rep 2017 Nov;21(8):2183-2197

Glioma and Neural Stem Cell Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors Team, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. Electronic address:

View Article
November 2017

Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma.

Neuro Oncol 2017 Oct;19(11):1469-1480

Pathobiology and Translational Science Graduate Program, Departments of Pathology and Laboratory Medicine, Biology, Pharmacology, Genetics, Medicine, and Neurology, Divisions of Neuropathology and Hematology/Oncology, Curriculum in Genetics and Molecular Biology, Lineberger Comprehensive Cancer Center, Proteomics Core Facility, Neurosciences Center, Carolina Institute for Developmental Disabilities, and Biological and Biomedical Sciences Program, University of North Carolina (UNC) School of Medicine, Chapel Hill, North Carolina; Cancer & Cell Biology Division, TGen, Phoenix, Arizona; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas.

View Article
October 2017

APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death.

Oncotarget 2017 Aug 21;8(33):54285-54296. Epub 2017 Apr 21.

Brain Tumor Center, Departments of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article
August 2017

CDK4/6 inhibition is more active against the glioblastoma proneural subtype.

Oncotarget 2017 Aug 21;8(33):55319-55331. Epub 2017 Jul 21.

Neuro-Oncology Division, Department of Neurology, University of Virginia, Charlottesville, VA, USA.

View Article
August 2017

Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.

Neuro Oncol 2017 Jul;19(7):965-975

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Neurology & Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York; Neuro-Oncology Unit, Erasmus MC Cancer Center, Rotterdam, the Netherlands; Department of Neurology, Northwestern University, Chicago, Illinois; Department of Neurology, NorthShore University HealthSystem, Evanston, Illinois; Department of Medical Oncology, Austin Health and Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia; School of Cancer Medicine, La Trobe University School of Cancer Medicine, Melbourne, Victoria, Australia; South Texas Accelerated Research Therapeutics (START), San Antonio, Texas; Department of Radiation Oncology, The University of Texas M.D.Anderson Cancer Center, Houston, Texas; AbbVie Inc., North Chicago, Illinois; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

View Article
July 2017

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Cancer Cell 2017 07;32(1):42-56.e6

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. Electronic address:

View Article
July 2017

Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.

Neuro Oncol 2017 05;19(5):660-668

Department of Neurosurgery, Unit 442, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article
May 2017

mA Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.

Cancer Cell 2017 04 23;31(4):591-606.e6. Epub 2017 Mar 23.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Program in Cancer Biology, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX 77030, USA. Electronic address:

View Article
April 2017

Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.

Acta Neuropathol 2017 Mar 27;133(3):431-444. Epub 2017 Jan 27.

Princess Margaret Cancer Centre, MacFeeters-Hamilton Brain Tumour Centre, College Street 101, Toronto, M5G 1L7, ON, Canada.

View Article
March 2017

Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors.

J Neuropathol Exp Neurol 2017 03;76(3):179-188

Department of Hematopathology, UT-MD Anderson Cancer Center, Houston, Texas, USA.

View Article
March 2017

Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.

J Oncol Pract 2017 Feb 29;13(2):123-127. Epub 2016 Nov 29.

The University of Texas MD Anderson Cancer Center, Houston, TX; American Society of Clinical Oncology, Alexandria, VA; University of California, San Francisco, CA.

View Article
February 2017

A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients.

J Neurosurg Anesthesiol 2017 Jan;29(1):46-58

*Department of Anesthesiology, Bern University Hospital Inselspital, Bern, Switzerland Departments of †Cancer Systems Imaging ‡Diagnostic Imaging §Neurosurgery and Brain Tumor Center ∥Radiation Oncology, Division of Radiation Oncology #Neurosurgery, Cancer Systems Imaging, and Cancer Biology **Cancer Systems Imaging, and Diagnostic Imaging, The University of Texas MD Anderson Cancer Center ¶Department of Neurosurgery, Baylor College of Medicine, Houston, TX.

View Article
January 2017

Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.

J Clin Oncol 2017 Jan 28;35(3):361-369. Epub 2016 Nov 28.

Erik P. Sulman and Terri S. Armstrong, MD Anderson Cancer Center; Terri S. Armstrong, University of Texas Health Science Center, Houston, TX; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; Christina Tsien, Washington University Physicians, St Louis, MO; Tracy T. Batchelor, Massachusetts General Hospital, Boston, MA; Tim Cloughesy, University of California, Los Angeles, Los Angeles; Mary Lovely and Susan M. Chang, University of California, San Francisco, San Francisco, CA; Evanthia Galanis, Mayo Clinic, Rochester, MN; Mark Gilbert, National Cancer Institute, Bethesda; Minesh Mehta, University of Maryland School of Medicine, Baltimore, MD; Vinai Gondi, Northwestern Medicine Cancer Center, Warrenville, IL; Matthew P. Mumber, Harbin Clinic Radiation Oncology, Rome, GA; and Andrew Sloan, University Hospitals Cleveland Medical Center, Cleveland, OH.

View Article
January 2017

A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways.

Nat Commun 2016 10 4;7:12885. Epub 2016 Oct 4.

Department of Neurology, Northwestern Brain Tumor Institute, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA.

View Article
October 2016

Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma.

J Natl Cancer Inst 2016 May 27;108(5). Epub 2015 Nov 27.

Department of Radiation Oncology (SKG, BLC, ACM, KKB, JLP, MAS, LC, GJK, JNS), Division of Medical Oncology (SHK), Molecular Pharmacology and Experimental Therapeutics (FBA, JMR), Division of Biomedical Statistics and Informatics (PAD, JEEP, KVB), and Laboratory Medicine and Pathology (GS, RBJ), Mayo Clinic, Rochester MN; The University of Texas, MD Anderson Cancer Center, Houston, TX (RGV, EPS).

View Article
May 2016

TERT Promoter Mutations and Risk of Recurrence in Meningioma.

J Natl Cancer Inst 2016 May 13;108(5). Epub 2015 Dec 13.

Affiliations of authors:Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University Heidelberg , Heidelberg , Germany (FS, DS, CK, DR, JB, AK, DC, SS, AvD); Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg , Germany (FS, DS, CK, DR, AK, DC, AvD); Department of Pathology (AO), Department of Genomic Medicine (QW), Department of Radiation Oncology (QW, EPS), and Department of Bioinformatics and Computational Biology (QW), The University of Texas MD Anderson Cancer Center , Houston, TX ; Department of Radiation Oncology (SA, JD) and Department of Neurosurgery (MSc, TU, CHM), University Hospital Heidelberg , Heidelberg , Germany ; Department of Neuropathology, Charité Medical University , Berlin , Germany (AK); Department of Pathology, University Hospital Nürnberg , Nürnberg , Germany (AFO): Department of Neurosurgery, Medical Faculty of the Ruprecht-Karls-University of Heidelberg , Mannheim , Germany (SB); Department of Neuropathology, Institute of Pathology and Neuropathology, University Tübingen , Tübingen , Germany (JS); Department of Neuropathology, University of Bonn , Bonn , Germany (AB); Department of Neurosurgery (BB) and Institute of Neuropathology (WP), University Hospital Münster , Münster , Germany (BB); Department of Neurosurgery, University Hospital Bonn , Bonn , Germany (KG, MSi); Department of Neurosurgery, University Hospital Würzburg , Würzburg , Germany (AFK); Department of Neurosurgery, University Hospital Hamburg , Hamburg , Germany (KL); Department of Neuropathology, Otto von Guericke University Magdeburg , Magdeburg , Germany (CM); Institute of Pathology, Saarland University , Homburg, Saarland , Germany (YJK); Department of Neurosurgery, Saarland University , Homburg , Germany (RK); MacFeeters-Hamilton Brain Tumour Centre, Princess Margaret Cancer Center , Toronto, Ontario , Canada (KDA); Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg , Germany (TH).

View Article
May 2016

TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1.

Sci Adv 2016 04 1;2(4):e1501290. Epub 2016 Apr 1.

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article
April 2016

Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy.

Radiother Oncol 2015 Nov 16;117(2):308-14. Epub 2015 Oct 16.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, United States. Electronic address:

View Article
November 2015

Genetic Modulation of Neurocognitive Function in Glioma Patients.

Clin Cancer Res 2015 Jul 22;21(14):3340-6. Epub 2015 Apr 22.

Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article
July 2015

Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification.

Semin Radiat Oncol 2015 Jul 23;25(3):155-63. Epub 2015 Feb 23.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article
July 2015

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Authors:
Daniel J Brat Roel G W Verhaak Kenneth D Aldape W K Alfred Yung Sofie R Salama Lee A D Cooper Esther Rheinbay C Ryan Miller Mark Vitucci Olena Morozova A Gordon Robertson Houtan Noushmehr Peter W Laird Andrew D Cherniack Rehan Akbani Jason T Huse Giovanni Ciriello Laila M Poisson Jill S Barnholtz-Sloan Mitchel S Berger Cameron Brennan Rivka R Colen Howard Colman Adam E Flanders Caterina Giannini Mia Grifford Antonio Iavarone Rajan Jain Isaac Joseph Jaegil Kim Katayoon Kasaian Tom Mikkelsen Bradley A Murray Brian Patrick O'Neill Lior Pachter Donald W Parsons Carrie Sougnez Erik P Sulman Scott R Vandenberg Erwin G Van Meir Andreas von Deimling Hailei Zhang Daniel Crain Kevin Lau David Mallery Scott Morris Joseph Paulauskis Robert Penny Troy Shelton Mark Sherman Peggy Yena Aaron Black Jay Bowen Katie Dicostanzo Julie Gastier-Foster Kristen M Leraas Tara M Lichtenberg Christopher R Pierson Nilsa C Ramirez Cynthia Taylor Stephanie Weaver Lisa Wise Erik Zmuda Tanja Davidsen John A Demchok Greg Eley Martin L Ferguson Carolyn M Hutter Kenna R Mills Shaw Bradley A Ozenberger Margi Sheth Heidi J Sofia Roy Tarnuzzer Zhining Wang Liming Yang Jean Claude Zenklusen Brenda Ayala Julien Baboud Sudha Chudamani Mark A Jensen Jia Liu Todd Pihl Rohini Raman Yunhu Wan Ye Wu Adrian Ally J Todd Auman Miruna Balasundaram Saianand Balu Stephen B Baylin Rameen Beroukhim Moiz S Bootwalla Reanne Bowlby Christopher A Bristow Denise Brooks Yaron Butterfield Rebecca Carlsen Scott Carter Lynda Chin Andy Chu Eric Chuah Kristian Cibulskis Amanda Clarke Simon G Coetzee Noreen Dhalla Tim Fennell Sheila Fisher Stacey Gabriel Gad Getz Richard Gibbs Ranabir Guin Angela Hadjipanayis D Neil Hayes Toshinori Hinoue Katherine Hoadley Robert A Holt Alan P Hoyle Stuart R Jefferys Steven Jones Corbin D Jones Raju Kucherlapati Phillip H Lai Eric Lander Semin Lee Lee Lichtenstein Yussanne Ma Dennis T Maglinte Harshad S Mahadeshwar Marco A Marra Michael Mayo Shaowu Meng Matthew L Meyerson Piotr A Mieczkowski Richard A Moore Lisle E Mose Andrew J Mungall Angeliki Pantazi Michael Parfenov Peter J Park Joel S Parker Charles M Perou Alexei Protopopov Xiaojia Ren Jeffrey Roach Thaís S Sabedot Jacqueline Schein Steven E Schumacher Jonathan G Seidman Sahil Seth Hui Shen Janae V Simons Payal Sipahimalani Matthew G Soloway Xingzhi Song Huandong Sun Barbara Tabak Angela Tam Donghui Tan Jiabin Tang Nina Thiessen Timothy Triche David J Van Den Berg Umadevi Veluvolu Scot Waring Daniel J Weisenberger Matthew D Wilkerson Tina Wong Junyuan Wu Liu Xi Andrew W Xu Lixing Yang Travis I Zack Jianhua Zhang B Arman Aksoy Harindra Arachchi Chris Benz Brady Bernard Daniel Carlin Juok Cho Daniel DiCara Scott Frazer Gregory N Fuller JianJiong Gao Nils Gehlenborg David Haussler David I Heiman Lisa Iype Anders Jacobsen Zhenlin Ju Sol Katzman Hoon Kim Theo Knijnenburg Richard Bailey Kreisberg Michael S Lawrence William Lee Kalle Leinonen Pei Lin Shiyun Ling Wenbin Liu Yingchun Liu Yuexin Liu Yiling Lu Gordon Mills Sam Ng Michael S Noble Evan Paull Arvind Rao Sheila Reynolds Gordon Saksena Zack Sanborn Chris Sander Nikolaus Schultz Yasin Senbabaoglu Ronglai Shen Ilya Shmulevich Rileen Sinha Josh Stuart S Onur Sumer Yichao Sun Natalie Tasman Barry S Taylor Doug Voet Nils Weinhold John N Weinstein Da Yang Kosuke Yoshihara Siyuan Zheng Wei Zhang Lihua Zou Ty Abel Sara Sadeghi Mark L Cohen Jenny Eschbacher Eyas M Hattab Aditya Raghunathan Matthew J Schniederjan Dina Aziz Gene Barnett Wendi Barrett Darell D Bigner Lori Boice Cathy Brewer Chiara Calatozzolo Benito Campos Carlos Gilberto Carlotti Timothy A Chan Lucia Cuppini Erin Curley Stefania Cuzzubbo Karen Devine Francesco DiMeco Rebecca Duell J Bradley Elder Ashley Fehrenbach Gaetano Finocchiaro William Friedman Jordonna Fulop Johanna Gardner Beth Hermes Christel Herold-Mende Christine Jungk Ady Kendler Norman L Lehman Eric Lipp Ouida Liu Randy Mandt Mary McGraw Roger Mclendon Christopher McPherson Luciano Neder Phuong Nguyen Ardene Noss Raffaele Nunziata Quinn T Ostrom Cheryl Palmer Alessandro Perin Bianca Pollo Alexander Potapov Olga Potapova W Kimryn Rathmell Daniil Rotin Lisa Scarpace Cathy Schilero Kelly Senecal Kristen Shimmel Vsevolod Shurkhay Suzanne Sifri Rosy Singh Andrew E Sloan Kathy Smolenski Susan M Staugaitis Ruth Steele Leigh Thorne Daniela P C Tirapelli Andreas Unterberg Mahitha Vallurupalli Yun Wang Ronald Warnick Felicia Williams Yingli Wolinsky Sue Bell Mara Rosenberg Chip Stewart Franklin Huang Jonna L Grimsby Amie J Radenbaugh Jianan Zhang

N Engl J Med 2015 Jun 10;372(26):2481-98. Epub 2015 Jun 10.

View Article
June 2015

Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.

Brain Pathol 2015 May 29;25(3):266-75. Epub 2014 Oct 29.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article
May 2015

Systematic identification of single amino acid variants in glioma stem-cell-derived chromosome 19 proteins.

J Proteome Res 2015 Feb 25;14(2):778-86. Epub 2014 Nov 25.

Department of Pharmacology and Toxicology and ‡Biochemistry and Molecular Biology, UTMB Cancer Center, University of Texas Medical Branch , Galveston, Texas 77555, United States.

View Article
February 2015

EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner.

Stem Cell Reports 2015 Feb 15;4(2):226-38. Epub 2015 Jan 15.

Department of Neurological Surgery, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA. Electronic address:

View Article
February 2015

Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer.

Int J Radiat Oncol Biol Phys 2014 Feb;88(2):357-62

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article
February 2014

A randomized trial of bevacizumab for newly diagnosed glioblastoma.

N Engl J Med 2014 Feb;370(8):699-708

From the University of Texas M.D. Anderson Cancer Center (M.R.G., T.S.A., J.S.W., P.D.B., I.W.T.-L., E.P.S., K.D.A.) and the University of Texas Health Science Center School of Nursing (T.S.A.), Houston; American College of Radiology (J.J.D., S.P., M.W.) and Thomas Jefferson University (M.W.-W.) - both in Philadelphia; the University of Chicago, Chicago (J.J.D.); Tel-Aviv Medical Center, Tel Aviv, Israel (D.T.B.); Cleveland Clinic, Cleveland (M.A.V.); the University of Utah, Salt Lake City (H.C.); Ohio State University, Columbus (A.C.); University of Wisconsin, Madison (R.J.); Mayo Clinic, Jacksonville, FL (K.A.J.); University of Virginia, Charlottesville (D.S.); Southeast Cancer Control Consortium, Winston-Salem, NC (V.W.S.); Barrow Neurologic Institute, Phoenix, AZ (D.G.B.); Emory University, Atlanta (W.J.C.); and the University of Maryland, Baltimore (M.P.M.).

View Article
February 2014

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.

Neuro Oncol 2014 Jan 4;16(1):81-91. Epub 2013 Dec 4.

Corresponding author: Daniel P. Cahill, MD, PhD, Department of Neurosurgery, 32 Fruit Street - Yawkey 9E, Massachusetts General Hospital, Brain Tumor Center/Neuro-Oncology, Boston, MA 02114.

View Article
January 2014

Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix.

Gynecol Oncol 2013 Dec 30;131(3):645-9. Epub 2013 Apr 30.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article
December 2013

Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells.

Cancer Res 2013 May 14;73(10):3062-74. Epub 2013 Mar 14.

Brain Tumor Center, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article
May 2013

Predictors of survival in contemporary practice after initial radiosurgery for brain metastases.

Int J Radiat Oncol Biol Phys 2013 Mar 14;85(3):656-61. Epub 2012 Aug 14.

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article
March 2013

Tumor prognostic factors and the challenge of developing predictive factors.

Curr Oncol Rep 2013 Feb;15(1):33-46

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article
February 2013

Management of brain metastasis: past lessons, modern management, and future considerations.

Curr Oncol Rep 2012 Feb;14(1):70-8

Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX 77030, USA.

View Article
February 2012

Bagged gene shaving for the robust clustering of high-throughput data.

Int J Bioinform Res Appl 2010 ;6(4):326-43

Department of Bioinformatics and Computational Biology, UT MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article
April 2011

Multigene sets for clinical application in glioma.

J Natl Compr Canc Netw 2011 Apr;9(4):449-56; quiz 457

Brain Tumor Center, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article
April 2011

Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors.

BMC Med Genomics 2011 Apr 14;4:34. Epub 2011 Apr 14.

Graduate Program in Structural and Computational Biology and Molecular Biophysics, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

View Article
April 2011

Tumor profiling: development of prognostic and predictive factors to guide brain tumor treatment.

Curr Oncol Rep 2011 Feb;13(1):26-36

Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX 77030, USA.

View Article
February 2011

The use of global profiling in biomarker development for gliomas.

Brain Pathol 2011 Jan;21(1):88-95

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Tex, USA.

View Article
January 2011

MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.

Neuro Oncol 2010 Feb 14;12(2):116-21. Epub 2009 Dec 14.

Departments of Pathology and Radiation-Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit-0097, Houston, TX 77030, USA.

View Article
February 2010

Beyond grade: molecular pathology of malignant gliomas.

Semin Radiat Oncol 2009 Jul;19(3):142-9

Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article
July 2009

IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

Int J Radiat Oncol Biol Phys 2009 Feb 14;73(2):399-409. Epub 2008 Jun 14.

Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article
February 2009

Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer.

Radiat Oncol 2009 Jan 30;4. Epub 2009 Jan 30.

Department of Radiation Oncology, the University of Texas M, D, Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, USA.

View Article
January 2009

Cancer stem cells: markers or biomarkers?

Cancer Metastasis Rev 2008 Sep;27(3):459-70

Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 1202, Houston, TX 77030, USA.

View Article
September 2008

Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation.

Int J Radiat Oncol Biol Phys 2007 Dec 27;69(5):1409-16. Epub 2007 Sep 27.

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article
December 2007

Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34.

Oncogene 2004 Jan;23(4):1014-20

The Fels Institute for Molecular Biology and Cancer Research, Temple University School of Medicine, Philadelphia, PA 19140, USA.

View Article
January 2004

Systematic evaluation of map quality: human chromosome 22.

Am J Hum Genet 2002 Jun 19;70(6):1398-410. Epub 2002 Apr 19.

Department of Genetics, Rutgers University, Piscataway, NJ 08854, USA.

View Article
June 2002